BENADRYL IM / IV
Pronunciation: dye-fen-HYE-dra-meen


What it isInjectable H1 and muscarinic antagonist; allergic reactions and acute dystonia or parkinsonism.
Why this oneThe B-52 ingredient: anticholinergic cover against haloperidol dystonia while it sedates.
What limits itSedation, delirium, urinary retention, and hypotension make its anticholinergic burden especially hazardous in older adults.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Allergic reactions/anaphylaxis adjunct, motion sickness, parkinsonism (when oral impractical) | Adults | 10–50 mg IV/IM (up to 100 mg if required) | 400 mg/day | |
| Allergic reactions, motion sickness, parkinsonism (when oral impractical) | Pediatric (not neonates/premature infants) | 5 mg/kg/day or 150 mg/m²/day IV/IM divided into 4 doses | 300 mg/day |
Renal Undefined.
Hepatic Undefined.
Available strengths
Pregnancy Undefined.
Lactation Contraindicated in nursing mothers (higher antihistamine risk for infants).
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 50 mg/mL | inj | per unit | $0.90/mL | not offered |
Other forms: Diphenhydramine (BENADRYL)
NO BOXED WARNINGS
Principal riskAnticholinergic burden; on every elderly deprescribing list
Open Diphenhydramine injection in the interactive console ↗
